Events

Program Overview VIRTUAL CONFERENCE Columbia University Irving Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high yield challenging scenarios in the management of ANCA-Vasculitis. Through a combination of lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice. Video Access Following the program, all registrants will be given access to lecture video recordings for one month. Learning Objectives 1. Discuss the basis of the pathogenesis of ANCA-Vasculitis. 2. Define renal pathology patterns of ANCA-Vasculitis. 3. Discuss pathogenesis, pathology, and immunosuppressive strategies available to health care providers (nephrologists, clinicians, pathologists, geneticist NP, and PAs). 4. Discuss ongoing clinical trials utilizing novel therapies for ANCA-Vasculitis. 5. Identify additional barriers to utilization for future educational opportunities. Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163. Physicians (ACCME) Credit Designation Statement Amedco LLC designates this live virtual activity for a maximum of x.x AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants PAs may claim a maximum of x.x Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society. Nurse Practitioners The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of x.x hours.

Program Overview VIRTUAL PROGRAM Columbia University Irving Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high yield challenging scenarios in the management of IgA Nephropathy. The half-day course is designed to enhance the knowledge of healthcare professionals on the IgAN updates including pathogenesis (with particular emphasis on the Gut-Renal axis) , genetics, pathology and non-immunosuppresive and  immunosuppressive strategies. Through a combination of lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice. Learning Objectives 1. Understand the pathophysiology of IgA nephropathy, including the role of IgA immune complexes in kidney inflammation and damage. 2. Describe the clinical presentation and diagnostic criteria for IgA nephropathy, including using kidney biopsy to confirm the diagnosis. 3. Explain the management of IgAN standard and novel targeted therapies. 4. Discuss the long-term outcomes of IgA nephropathy, such as the risk of progressive kidney disease and end-stage renal failure using risk calculators. 5. Target the role of B-Cell therapies. 6. Analyze the impact of personalized medicine approaches, such as biomarkers and genetic factors, on diagnosing and managing IgA nephropathy. Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163. Physicians (ACCME) Credit Designation Statement Amedco LLC designates this live virtual activity for a maximum of x.x AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants PAs may claim a maximum of x.x Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society. Nurse Practitioners The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of x.x hours.

Program Overview
 IN-PERSON & VIRTUAL CONFERENCE Please note:  In-person registration includes light breakfast and lunch Video Access Following the live program, all registrants will have access to lecture video recordings for one month. Learning Objectives TBD   Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 Amedco Joint Accreditation #4008163.         Physicians (ACCME) Credit Designation Statement
 Amedco LLC designates this live virtual activity for a maximum of x.x AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 Physician Assistants PAs may claim a maximum of x.x Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society. Nurse Practitioners The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of x.x hours.

Program Overview IN-PERSON, HANDS-ON 2-DAY PROGRAM Available Dates Monday & Tuesday, July 21 & 22, 2025 or Thursday & Friday, July 24 & 25, 2025 Advances in the use of ultrasonography enhance our ability to better characterize acute kidney injury (AKI) and volume assessment in critically ill patients. The initial approach to AKI differentiates between pre-renal, intrinsic, and post-renal/obstructive AKI. Pre-renal AKI results from decreased perfusion of the kidney parenchyma. Intrinsic AKI is an insult that progresses to damage of the kidney tubules and/or direct damage to the nephron itself. Post-renal AKI develops from blockage after the kidney collecting system, such as nephrolithiasis, malignancy compressing a ureter, or prostatic hypertrophy. Pre-renal and post-renal injuries can be reversible, but prolonged injury may develop into intrinsic AKI. The rapid diagnosis of pre- and post-renal obstruction can lead to reversal; ultrasonography through high quality imaging is therefore critical for clinical care, and identification of chronic kidney disease (CKD). Assessment of volume status is an essential component to the care of both the critically ill patient and the care of patient with heart and renal failure. Volume resuscitation management is guided by often inaccurate methods, leading to delays in care management decisions. While volume depletion and decreased cardiac output lead to end organ damage and increased morbidity and mortality, so too does fluid overload lead to pulmonary edema and respiratory failure, heart failure, AKI, hepatic congestion, tissue breakdown and impaired bowel function. POCUS offers additional methods of volume assessment through lung imaging to evaluate for interstitial edema and pleural effusions. A focused cardiac evaluation with POCUS can also be helpful for non-cardiologist physicians in identifying left ventricular dysfunction, valvular dysfunction and pericardial effusions. Point of Care Ultrasound (POCUS) enhances ability to characterize acute kidney injury and volume assessment in critically ill patients. Challenges to POCUS training for nephrologists include: relatively new use of POCUS, physicians lack POCUS training, and lack of POCUS in graduate medical education. Our objective is to train nephrologists utilizing a 2-day curriculum that satisfys POCUS certification through the American Society of Diagnostic and Interventional Nephrology.     Learning Objectives 1. Point of care Ultrasound targets acute kidney injury and volume assessment in critically ill patients through POCUS. 2. Identify and train nephrologists utilizing a 2-day curriculum that satisfies POCUS certification through the American Society of Diagnostic and Interventional Nephrology. 3. Discuss and train the uses of POCUS with physicians and graduate medical education students who lack POCUS training. Credit Information This course will satisfy the instructional requirements (8 hours CME didactic training, 8 hours CME hands-on course) for the American Society of Diagnostic and Interventional Nephrology for POCUS. Please refer to the POCUS application on the ASDIN website for details https://www.asdin.org/page/RUSCert